New Delhi: Intas Pharma has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug ...

Karnataka: Shilpa Medicare's Joint Venture Oncosol (50:50 JV with Liqmeds Lifecare Limited, a Zydus group company and Koana ...

Despite significant advancements in reproductive endocrinology and infertility over the past decade, systemic inequities ...

A recent study published in Clinical Interventions in Aging found that among 479 patients aged 80 and older undergoing femur ...

Anakapalli: In a devastating incident at a private pharma company located in Parawada Pharma City, one worker died, and two ...

In relation to the successful completion of Phase I clinical trials, Shilpa Medicare Ltd has announced that the Subject ...

The Union Health Ministry, in a response to an RTI dated November 7, disclosed that the proposed amendments to the Drugs and ...

Jhansi: Days after the devastating blaze in the Neonatal intensive care unit (NICU) of Maharani Laxmi Bai Medical College in ...

A recent study published in the journal Scientific Reports correlates higher levels of pollutant particulate matter to higher ...

Chennai: Unveiling a postgraduate medical admission scam in Tamil Nadu, the Directorate of Medical Education found during ...

There was a major standoff between doctors and police officials recently at Delhi's Safdarjung Hospital after a resident ...

Short-term menopausal hormone therapy (MHT) did not have long-term cognitive effects when given to women in early ...